Medicare Enrolled

Dr. Leslie Markle, MD

Dermatology · Tyler, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1367 DOMINION PLZ, Tyler, TX 75703
9035346200
In practice since 2009 (16 years)
NPI: 1225264443 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Markle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Markle? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Markle

Dr. Leslie Markle is a dermatology specialist in Tyler, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Markle performed 10,610 Medicare services across 4,959 unique beneficiaries.

Between the years covered by Open Payments, Dr. Markle received a total of $8,427 from 28 pharmaceutical and/or device companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Markle is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 8% volume in TX $8,427 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,610
Medicare services
Top 8% in TX for dermatology
4,959
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~663 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 5,104 $5 $23
Office visit, established patient (20-29 min) 1,817 $58 $297
Destruction of precancerous skin growth, 1 1,212 $35 $223
Destruction of skin growths (warts/lesions), 1-14 544 $74 $378
Skin biopsy, tangential 508 $62 $338
Office visit, established patient (30-39 min) 188 $83 $420
Biopsy of related skin growth, each additional growth 175 $37 $168
New patient office visit (30-44 min) 144 $64 $369
Destruction of precancer skin growth, 15 or more growths 127 $117 $562
Steroid injection (triamcinolone) 110 $1 $24
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm 76 $216 $1,011
Office visit, established patient (10-19 min) 68 $35 $186
Biopsy of ear 55 $48 $321
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm 52 $91 $492
Blood draw (venipuncture) 45 $8 $10
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less 44 $180 $878
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm 41 $94 $813
Injection into skin growth, 1-7 growths 38 $31 $190
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm 33 $104 $927
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 29 $123 $594
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm 29 $104 $554
All potassium hydroxide (koh) preparations 27 $6 $19
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm 22 $66 $572
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm 21 $93 $839
Destruction of skin growth, 15 or more growths 21 $99 $441
Intermediate repair of wound of neck, hands, feet, or genitals, 2.5 cm or less 18 $191 $881
Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm 18 $211 $1,031
Punch biopsy, first skin growth 15 $90 $419
Tissue fungi or parasites 15 $4 $24
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm 14 $114 $598
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,427
Total received (2018-2024)
Avg $1,204/year across 7 years
Top 31% in TX for dermatology
28
Companies
442
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,427 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,235
2023
$1,789
2022
$1,808
2021
$982
2020
$646
2019
$539
2018
$428

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,853
Janssen Biotech, Inc.
$1,700
Regeneron Healthcare Solutions, Inc.
$730
AbbVie Inc.
$581
GENZYME CORPORATION
$562
Lilly USA, LLC
$468
AbbVie, Inc.
$400
Novartis Pharmaceuticals Corporation
$395
Sun Pharmaceutical Industries Inc.
$297
E.R. Squibb & Sons, L.L.C.
$265
UCB, Inc.
$183
LEO Pharma Inc.
$162
Medtronic, Inc.
$144
PFIZER INC.
$125
Amgen Inc.
$88
SUN PHARMACEUTICAL INDUSTRIES INC.
$67
Arcutis Biotherapeutics, Inc.
$62
Almirall LLC
$61
Incyte Corporation
$50
Janssen Scientific Affairs, LLC
$44
Dermavant Sciences, Inc.
$37
Galderma Laboratories, L.P.
$34
Kyowa Kirin, Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
MAYNE PHARMA INC.
$22
Helsinn Therapeutics (U.S.), Inc.
$16
Celgene Corporation
$14
EPI Health, LLC
$12
Top 3 companies account for 50.8% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · Absorica LD · BLU-U · Bimzelx · COSENTYX · Cimzia · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EUCRISA · HUMIRA · Humira · ILUMYA · LIBTAYO · OLUMIANT · OPZELURA · ORACEA · Otezla · POTELIGEO · REMICADE · RINVOQ · SKYRIZI · SPEVIGO · SURGIPRO LL · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · Tremfya · ULTRAVATE · VALCHLOR · VTAMA · Winlevi · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $79 per 100 Medicare services performed
Looking for a dermatology specialist in Tyler?
Compare dermatologists in the Tyler area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
14
Per 100K population
5.9
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
6.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Markle is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), with low-engagement industry engagement, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Markle experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Markle performed 5,104 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Markle receive payments from pharmaceutical companies?
Yes. Dr. Markle received a total of $8,427 from 28 companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Markle's costs compare to other dermatologists in Tyler?
Dr. Markle's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Markle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →